CLEMASTINE 2MG/2ML INJ AMP - PC.00728.2026

This tender, identified by the reference number PC.00728.2026, concerns the procurement of "CLEMASTINE 2MG/2ML INJ AMP". This refers to Clemastine, an antihistamine medication, specifically in an injectable form with a concentration of 2mg per 2ml, presented in ampoules (AMP). The tender is seeking suppliers for this pharmaceutical product, likely for use in clinical settings such as hospitals or emergency services. The procurement is scheduled for the year 2026. The contracting entity requires a reliable supply of this medication, which is used to treat allergic reactions. Bidders will need to ensure their product meets all relevant pharmaceutical quality standards, regulatory requirements, and specific technical specifications outlined in the tender documents. The tender aims to secure the necessary supply of Clemastine injections to meet patient needs. Further details regarding the required quantities, delivery timelines, and specific formulation requirements are expected to be available in the full tender documentation. This procurement is crucial for ensuring the availability of essential medications for patient care.

This is a supplies contract in the health and medical services, trade and industry and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 11,850.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.